Shanliang Zhong

Mr. Shanliang Zhong


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
XLXue-Min Liu
Xue-Min Liu
MLMeng-Meng Lv
Meng-Meng Lv
LCLin Chen
Lin Chen
JZJian-Hua Zhao
Jian-Hua Zhao
JTJin-hai Tang
Jin-hai Tang
Adriamycin and docetaxel are two agents commonly used in treatment of breast cancer, but their efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development and progression. However, the specific contribution of breast cancer-derived exosomes is poorly understood. Here we reinforced other's report that human breast cancer cell line MCF-7/S could acquire increased survival potential from its resistant variants MCF-7/Adr and MCF-7/Doc. Additionally, exosomes of the latter, A/exo and D/exo, significantly modulated the cell cycle distribution and drug-induced apoptosis with respect to S/exo. Exosomes pre-treated with RNase were unable to regulate cell cycle and apoptosis resistance, suggesting an RNA-dependent manner. Microarray and polymerase chain reaction for the miRNA expression profiles of A/exo, D/exo, and S/exo demonstrated that they loaded selective miRNA patterns. Following A/exo and D/exo transfer to recipient MCF-7/S, the same miRNAs were significantly increased in acquired cells. Target gene prediction and pathway analysis showed the involvement of miR-100, miR-222, and miR-30a in pathways implicated in cancer pathogenesis, membrane vesiculation and therapy failure. Furthermore, D/exo co-culture assays and miRNA mimics transfection experiments indicated that miR-222-rich D/exo could alter target gene expression in MCF-7/S. Our results suggest that drug-resistant breast cancer cells may spread resistance capacity to sensitive ones by releasing exosomes and that such effects could be partly attributed to the intercellular transfer of specific miRNAs.

31 July 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
MLMeng-Meng Lv
Meng-Meng Lv
XZXing-Ya Zhu
Xing-Ya Zhu
WCWei-Xian Chen
Wei-Xian Chen
SZShanliang Zhong
Shanliang Zhong
QHQing Hu
Qing Hu
JZJian-Hua Zhao
Jian-Hua Zhao

1 June 2015 in Cancer Treatment Reviews
Verified
Journal Article
Closed access
SZShanliang Zhong
Shanliang Zhong
XZXiaohui Zhang
Xiaohui Zhang
LCLin Chen
Lin Chen
TMTengfei Ma
Tengfei Ma
JTJinhai Tang
Jinhai Tang
JZJianhua Zhao
Jianhua Zhao

27 June 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
YCYan-Qin Cai
Yan-Qin Cai
MLMeng-Meng Lv
Meng-Meng Lv
LCLin Chen
Lin Chen
SZShanliang Zhong
Shanliang Zhong
JTJin-hai Tang
Jin-hai Tang

1 November 2013 in Gene
Verified
Journal Article
Closed access
SZShanliang Zhong
Shanliang Zhong
WLWenjing Li
Wenjing Li
ZCZhiyuan Chen
Zhiyuan Chen
JXJinjin Xu
Jinjin Xu
JZJianhua Zhao
Jianhua Zhao

4 April 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
XYXinnian Yu
Xinnian Yu
LXLinjun Xie
Linjun Xie
JGJianjuan Ge
Jianjuan Ge
HLHuixin Li
Huixin Li
SZShanliang Zhong
Shanliang Zhong
XLXiaolin Liu
Xiaolin Liu
Objectives: The tumor microenvironment (TME) play important roles in progression of endometrial carcinoma (EC). We aimed to assess the cell populations in TME of EC.Methods: We downloaded datasets of single-cell RNA-seq (scRNA-seq) and spatial transcriptome (ST) for EC from GEO, and downloaded RNA-Seq (FPKM) and clinical data of TCGA-UCEC project from TCGA. The datasets were analyzed using R software.Results: We obtained 5 datasets of scRNA-seq, 1 of ST and 569 samples of RNA-seq. Totally, 0.2 billion transcripts and 33,408 genes were detected in 33,162 cells from scRNA-seq. The cells were classified into 9 clusters, and EC cells were originated from epithelial cells and ciliated cells. Gene set variation analysis (GSVA) indicated that the pathways enriched in the subclusters of epithelial cells and endothelial cells were significantly different, indicating great heterogeneity in EC. Cell-cell communication analyses showed that EC cells emitted the strongest signals, and endothelial cells received more signals than other cells. Further analysis found that subclusters of 1 and 2 of epithelial cells were showed a more malignant phenotype, which may confer malignant phenotype to subcluster of 0 of endothelial cells through MK pathway by MDL-NCL signal. We also analyzed communications between spatial neighbors with ST data and confirmed the findings on MDL-NCL in cell-cell communication. TCGA and GEO analyses indicated that the expression levels of NCL was inversely correlated with ImmuneScore.Conclusion: Our study revealed EC cells can confer malignant phenotype to endothelial cells by MDK-NCL signal, and NCL is associated with suppressed immune activity. EC cells may shape TME by inhibiting immune cells and “educating” stromal cells via MDK-NCL signal.